within Pharmacolibrary.Drugs.V_Various.V04C_OtherDiagnosticAgents.V04CE02_Sulfobromophthalein;

model Sulfobromophthalein
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 3.5000000000000004e-06,
    adminDuration = 600,
    adminMass = 5 / 1000000,
    adminCount = 1,
    Vd = 0.00011999999999999999,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 7.000000000000001e-05,
    k12 = 8.75e-06,
    k21 = 8.75e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Sulfobromophthalein</td></tr><tr><td>ATC code:</td><td>V04CE02</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.12</td><td>L</td></tr>
    <tr><td>clearance:</td><td>3.0</td><td>ml/kg/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Sulfobromophthalein (BSP) is a synthetic dye previously used as a diagnostic agent to evaluate liver function via the BSP retention test, which measured hepatic uptake, conjugation, and excretion. Its clinical use has declined significantly and is largely obsolete today, having been replaced by more modern testing methods.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetics in healthy adult participants following intravenous bolus administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V04CE02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Sulfobromophthalein;
